2010
DOI: 10.1007/s00213-010-1860-5
|View full text |Cite
|
Sign up to set email alerts
|

Chronic treatment with a selective inhibitor of casein kinase I δ/ε yields cumulative phase delays in circadian rhythms

Abstract: The magnitude of the shifts in activity onsets achieved with chronic dosing of PF-670462 appears to be a function of the dose and the previously established phase relationship. Its cumulative effect further suggests that the pharmacodynamic t (1/2) of the drug greatly exceeds its pharmacokinetic one. Most importantly, these changes in circadian behavior occurred in the presence of a fixed L:D cycle, confirming the drug to be a robust modulator of circadian phase in the presence of the natural zeitgeber.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
17
0

Year Published

2011
2011
2018
2018

Publication Types

Select...
4
4
1

Relationship

0
9

Authors

Journals

citations
Cited by 26 publications
(19 citation statements)
references
References 46 publications
(57 reference statements)
2
17
0
Order By: Relevance
“…As previously mentioned, CK1␦/ε inhibition impairs the circadian clock through induction of phase delays in rats under free running conditions (7). Cynomolgus monkeys also display a similar phase delay (39), and time of dosing affects the phase shifting (38). In addition to this role in regulation of the Fig.…”
Section: Discussionmentioning
confidence: 92%
“…As previously mentioned, CK1␦/ε inhibition impairs the circadian clock through induction of phase delays in rats under free running conditions (7). Cynomolgus monkeys also display a similar phase delay (39), and time of dosing affects the phase shifting (38). In addition to this role in regulation of the Fig.…”
Section: Discussionmentioning
confidence: 92%
“…An inhibitor specific for CK1ε (PF-4800567) has only a slight effect on the period of oscillating rat-1 fibroblasts stably transfected with a Per2::luc reporter compared to the dual CK1δ/ε inhibitor (PF-670462) which causes an increase in fibroblast circadian period (Walton et al ., 2009). Single injections into rats of the dual CK1δ/ε inhibitor induce large phase delays in circadian locomotor rhythms under free-running and entrained conditions (Badura et al ., 2007; Sprouse et al ., 2010). Daily treatment with PF-670462 significantly lengthens locomotor behavioral rhythms in a dose-dependent manner in wild-type, CK1 ε tau , and CK1ε −/− mice (Meng et al ., 2010).…”
Section: Posttranslational Modification Of Clock Proteinsmentioning
confidence: 99%
“…Both isoforms belong to the superfamily of serine/threonine-specific kinases that play a major role in regulating and sustaining the pace of the molecular clock by phosphorylating circadian proteins, BMAL1, CRY, PER1 and PER2 (Eide, Kang, Crapo, Gallego, & Virshup, 2005; Meng et al, 2008). PER2 is rhythmically destabilized by CK1 ε / δ phosphorylation (Eide et al, 2005; Etchegaray et al, 2009; Meng et al, 2008), and pharmacological inhibition of CK1 ε / δ induces phase delays of circadian locomotor activity, enhances PER2 protein levels, and inhibits nuclear translocation of PER3 (Badura et al, 2007; Sprouse et al, 2010). CK1 ε / δ inhibition also inhibits PER3 nuclear translocation (Sprouse et al, 2010).…”
Section: Circadian Gene Mutations and Alcohol Seeking And Rewardmentioning
confidence: 99%
“…PER2 is rhythmically destabilized by CK1 ε / δ phosphorylation (Eide et al, 2005; Etchegaray et al, 2009; Meng et al, 2008), and pharmacological inhibition of CK1 ε / δ induces phase delays of circadian locomotor activity, enhances PER2 protein levels, and inhibits nuclear translocation of PER3 (Badura et al, 2007; Sprouse et al, 2010). CK1 ε / δ inhibition also inhibits PER3 nuclear translocation (Sprouse et al, 2010). CK1 ε / δ is associated with behavioral responses to other drugs of abuse (Bryant et al, 2009; Bryant et al, 2012).…”
Section: Circadian Gene Mutations and Alcohol Seeking And Rewardmentioning
confidence: 99%